BRAF mutations in thyroid tumors from an ethnically diverse group

Schulten Hans-Juergen, Salama Sherine, Al-Mansouri Zuhoor, Alotibi Reem, Al-Ghamdi Khalid, Al-Hamour Osman, Sayadi Hassan, Al-Aradati Hosam, Al-Johari Adel, Huwait Etimad, Gari Mamdooh, Al-Qahtani Mohammed, Al-Maghrabi Jaudah

Description

The molecular etiology of thyroid carcinoma (TC) and other thyroid diseases which may present malignant precursor lesions is not fully explored yet. The purpose of this study was to estimate frequency, type and clinicopathological value of BRAF exon 15 mutations in different types of cancerous and non-cancerous thyroid lesions originating in an ethnically diverse population. Methods BRAF exon 15 was sequenced in 381 cases of thyroid lesions including Hashimoto´s thyroiditis, nodular goiters, hyperplastic nodules, follicular adenomas (FA), papillary TC (PTC), follicular variant PTC (FVPTC), microcarcinomas of PTC (micro PTC; tumor size ≤ 1 cm), follicular TC (FTC), and non-well differentiated TC (non-WDTC). Results We identified BRAF mutations in one of 69 FA, 72 of 115 (63%) PTC, seven of 42 (17%) FVPTC, 10 of 56 (18%) micro PTC, one of 17 (6%) FTC, and one of eight (13%) non-WDTC. Most of the cases showed the common V600E mutation. One case each of PTC, FVPTC, and FTC harbored a K601E mutation. A novel BRAF mutation was identified in a FA leading to deletion of threonine at codon 599 (p.T599del). A rare 3-base pair insertion was detected in a stage III PTC resulting in duplication of threonine at codon 599 (p.T599dup). Patients with PTC harboring no BRAF mutation (BRAF wt ) were on average younger than those with a BRAF mutation (BRAF mut ) in the PTC (36.6 years vs. 43.8 years). Older age (≥ 45 years) in patients with PTC was significantly associated with tumor size ≥ 4 cm (P = 0.018), vessel invasion (P = 0.004), and distant metastasis (P = 0.001). Lymph node (LN) involvement in PTC significantly correlated with tumor size (P = 0.044), and vessel invasion (P = 0.013). Of notice, taken the whole TC group, family history of thyroid disease positively correlated with capsular invasion (P = 0.025). Conclusions Older age is manifold associated with unfavorable tumor markers in our series. The K601E identified in a PTC, FVPTC, and FTC seems to be more distributed among different histological types of TC than previously thought. The T599del is a yet undescribed mutation and the rare T599dup has not been reported as a mutation in PTC so far.

Sujets

• Thyroid neoplasm
• Family history
• MENA

Informations

• Publié par: biomed
• Publié le: 01 janvier 2012
• Nombre de lectures: 143
• Langue: English
• Poids de l'ouvrage: 1 Mo

Extrait

Schultenet al. Hereditary Cancer in Clinical Practice2012,10:10 http://www.hccpjournal.com/content/10/1/10

R E S E A R C HOpen Access BRAF mutations in thyroid tumors from an ethnically diverse group 1* 23 45 HansJuergen Schulten, Sherine Salama , Zuhoor AlMansouri , Reem Alotibi , Khalid AlGhamdi , 6 33 54 1 Osman Abdel AlHamour , Hassan Sayadi , Hosam AlAradati , Adel AlJohari , Etimad Huwait , Mamdooh Gari , 1 2,3 Mohammed Hussain AlQahtaniand Jaudah AlMaghrabi

Abstract Background:The molecular etiology of thyroid carcinoma (TC) and other thyroid diseases which may present malignant precursor lesions is not fully explored yet. The purpose of this study was to estimate frequency, type and clinicopathological value of BRAF exon 15 mutations in different types of cancerous and noncancerous thyroid lesions originating in an ethnically diverse population. Methods:BRAF exon 15 was sequenced in 381 cases of thyroid lesions including Hashimoto´s thyroiditis, nodular goiters, hyperplastic nodules, follicular adenomas (FA), papillary TC (PTC), follicular variant PTC (FVPTC), microcarcinomas of PTC (micro PTC; tumor size≤1 cm), follicular TC (FTC), and nonwell differentiated TC (nonWDTC). Results:We identified BRAF mutations in one of 69 FA, 72 of 115 (63%) PTC, seven of 42 (17%) FVPTC, 10 of 56 (18%) micro PTC, one of 17 (6%) FTC, and one of eight (13%) nonWDTC. Most of the cases showed the common V600E mutation. One case each of PTC, FVPTC, and FTC harbored a K601E mutation. A novel BRAF mutation was identified in a FA leading to deletion of threonine at codon 599 (p.T599del). A rare 3base pair insertion was detected in a stage III PTC resulting in duplication of threonine at codon 599 (p.T599dup). Patients with PTC wt mut harboring no BRAF mutation (BRAF) were on average younger than those with a BRAF mutation (BRAF) in the PTC (36.6 years vs. 43.8 years). Older age (≥45 years) in patients with PTC was significantly associated with tumor size≥4 cm (P = 0.018), vessel invasion (P = 0.004), and distant metastasis (P = 0.001). Lymph node (LN) involvement in PTC significantly correlated with tumor size (P = 0.044), and vessel invasion (P = 0.013). Of notice, taken the whole TC group, family history of thyroid disease positively correlated with capsular invasion (P = 0.025). Conclusions:Older age is manifold associated with unfavorable tumor markers in our series. The K601E identified in a PTC, FVPTC, and FTC seems to be more distributed among different histological types of TC than previously thought. The T599del is a yet undescribed mutation and the rare T599dup has not been reported as a mutation in PTC so far. Keywords:BRAF mutations, Deletion codon 599, Duplication codon 599, Thyroid carcinoma, Follicular adenoma, Family history, MENA region

* Correspondence: [e-mail] 1 Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia Full list of author information is available at the end of the article

© 2012 Schulten et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.